Outlook Therapeutics (OTLK) Times Interest Earned (2016 - 2020)
Historic Times Interest Earned for Outlook Therapeutics (OTLK) over the last 6 years, with Q2 2020 value amounting to -$26.78.
- Outlook Therapeutics' Times Interest Earned fell 41322.8% to -$26.78 in Q2 2020 from the same period last year, while for Jun 2025 it was -$105.46, marking a year-over-year change of. This contributed to the annual value of -$22.71 for FY2024, which is 821.57% down from last year.
- According to the latest figures from Q2 2020, Outlook Therapeutics' Times Interest Earned is -$26.78, which was down 41322.8% from -$9.72 recorded in Q1 2020.
- In the past 5 years, Outlook Therapeutics' Times Interest Earned registered a high of -$1.36 during Q3 2017, and its lowest value of -$73.56 during Q2 2016.
- In the last 5 years, Outlook Therapeutics' Times Interest Earned had a median value of -$8.28 in 2018 and averaged -$16.95.
- In the last 5 years, Outlook Therapeutics' Times Interest Earned soared by 9428.66% in 2017 and then plummeted by 72867.66% in 2018.
- Quarter analysis of 5 years shows Outlook Therapeutics' Times Interest Earned stood at -$36.38 in 2016, then skyrocketed by 87.82% to -$4.43 in 2017, then crashed by 106.61% to -$9.15 in 2018, then crashed by 49.63% to -$13.69 in 2019, then crashed by 95.55% to -$26.78 in 2020.
- Its last three reported values are -$26.78 in Q2 2020, -$9.72 for Q1 2020, and -$13.69 during Q4 2019.